A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-26
DOI
10.1038/s41398-020-00897-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
- (2019) Samuel T. Wilkinson et al. NEUROPSYCHOPHARMACOLOGY
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
- (2019) Gihyun Yoon et al. JAMA Psychiatry
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
- (2019) Jennifer L. Phillips et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
- (2018) Mark J. Niciu et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
- (2018) C. Sophia Albott et al. JOURNAL OF CLINICAL PSYCHIATRY
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
- (2017) C. Sophia Albott et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
- (2016) Melvyn W. Zhang et al. BMC Medical Ethics
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
- (2014) Mark J. Niciu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
- (2013) Paulo R. Shiroma et al. JOURNAL OF AFFECTIVE DISORDERS
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
- (2009) Celia J. A. Morgan et al. ADDICTION
- The clinical relevance of changes in the Montgomery–Asberg Depression Rating Scale using the minimum clinically important difference approach
- (2008) Gérard Duru et al. CURRENT MEDICAL RESEARCH AND OPINION
- Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
- (2008) George I. Papakostas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started